Literature DB >> 14622732

Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports.

Carlton Dampier1, Beth Ely, Darcy Brodecki, Patricia O'Neal.   

Abstract

Pain can begin in the first year of life for individuals with sickle cell disease (SCD) and continue in an unpredictably recurrent manner throughout their life span. Sickle vaso-occlusive pain (sickle pain) can also occur simultaneously with pain of other origins, complicating both assessment and management. Aims of this research were to describe the reliability and validity of a daily diary for data collection with children and adolescents with SCD and to describe characteristics of vaso-occlusive sickle pain episodes (VOE) and other pain reported by children and adolescents with SCD along with home pain management strategies. Thirty-nine children and adolescents (mean age, 10.9 +/- 3.6 years) completed diaries twice daily at home for up to 3 years (mean, 417.9 +/- 272.2 diary days) with excellent compliance. Sickle pain alone was reported on 8.4% of days (n = 1515 days), whereas other pain occurred on 2.7% of days (n = 490) and both sickle pain and other pain on 5.7% (n = 1041 days). Other pain only episodes were shorter and involved fewer sites than sickle pain only episodes. Sickle pain occurred in the extremities and hips, whereas most other pain occurred in the head-neck area. Analgesic medication was taken on 85% of days of sickle pain, whereas analgesics were taken on only 60% of days with other pain. The diary used in this study is a valid and reliable self-report tool. The use of home diaries will improve the understanding of sickle pain and its management and assist in identifying other pain syndromes that may require alternative management.

Entities:  

Year:  2002        PMID: 14622732     DOI: 10.1054/jpai.2002.128064

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  44 in total

1.  Pain site frequency and location in sickle cell disease: the PiSCES project.

Authors:  Donna K McClish; Wally R Smith; Bassam A Dahman; James L Levenson; John D Roberts; Lynne T Penberthy; Imoigele P Aisiku; Susan D Roseff; Viktor E Bovbjerg
Journal:  Pain       Date:  2009-07-23       Impact factor: 6.961

Review 2.  Psychological Predictors of Pain in Children and Adolescents With Sickle Cell Disease: A Scoping Review.

Authors:  Clare Donohoe; Ellen Lavoie Smith
Journal:  J Pediatr Oncol Nurs       Date:  2018-12-19       Impact factor: 1.636

3.  Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease.

Authors:  Carlton Dampier; Beth Ely; Darcy Brodecki; Camille Coleman; Leela Aertker; Jocelyn Andrel Sendecki; Benjamin Leiby; Karen Kesler; Terry Hyslop; Marie Stuart
Journal:  Pediatr Blood Cancer       Date:  2013-09-24       Impact factor: 3.167

4.  The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients.

Authors:  Wally R Smith; Samir K Ballas; William F McCarthy; Robert L Bauserman; Paul S Swerdlow; Martin H Steinberg; Myron A Waclawiw
Journal:  Pain Med       Date:  2011-04-11       Impact factor: 3.750

5.  Changes in Pain and Psychosocial Functioning and Transition to Chronic Pain in Pediatric Sickle Cell Disease: A Cohort Follow-up Study.

Authors:  Soumitri Sil; Lindsey L Cohen; Nitya Bakshi; Amanda Watt; Morgan Hathaway; Farida Abudulai; Carlton Dampier
Journal:  Clin J Pain       Date:  2020-06       Impact factor: 3.442

6.  Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease.

Authors:  Robert E Molokie; Diana J Wilkie; Harriett Wittert; Marie L Suarez; Yingwei Yao; Zhongsheng Zhao; Ying He; Zaijie J Wang
Journal:  Eur J Pharmacol       Date:  2013-11-07       Impact factor: 4.432

7.  Understanding the experiences of youth living with sickle cell disease: a photovoice pilot.

Authors:  Jessica M Valenzuela; Lisa M Vaughn; Lori E Crosby; Heather Strong; Alexandra Kissling; Monica J Mitchell
Journal:  Fam Community Health       Date:  2013 Apr-Jun

8.  IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.

Authors:  Carlton D Dampier; Wally R Smith; Carrie G Wager; Hae-Young Kim; Margaret C Bell; Scott T Miller; Debra L Weiner; Caterina P Minniti; Lakshmanan Krishnamurti; Kenneth I Ataga; James R Eckman; Lewis L Hsu; Donna McClish; Sonja M McKinlay; Robert Molokie; Ifeyinwa Osunkwo; Kim Smith-Whitley; Marilyn J Telen
Journal:  Clin Trials       Date:  2013-04       Impact factor: 2.486

9.  Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events.

Authors:  Amanda M Brandow; David C Brousseau; Julie A Panepinto
Journal:  Br J Haematol       Date:  2008-12-01       Impact factor: 6.998

10.  Negative thinking as a coping strategy mediator of pain and internalizing symptoms in adolescents with sickle cell disease.

Authors:  Lamia P Barakat; Lisa A Schwartz; Katherine Simon; Jerilynn Radcliffe
Journal:  J Behav Med       Date:  2007-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.